Genes Affecting the Cell Cycle, Growth, Maintenance, and Drug Sensitivity Are Preferentially Regulated by Anti-HER2 Antibody through Phosphatidylinositol 3-Kinase-AKT Signaling

This publication has 34 references indexed in Scilit:

• The ErbB receptors and their role in cancer progression
  Experimental Cell Research, 2003
• The Human and Mouse Replication-Dependent Histone Genes
  Genomics, 2002
• The Human and Mouse Replication-Dependent Histone Genes
  Genomics, 2002
• A Role for PI 3-Kinase and PKB Activity in the G2/M Phase of the Cell Cycle
  Current Biology, 2002
• ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth
  Oncogene, 2001
• Mechanism of action of trastuzumab and scientific update
  Seminars in Oncology, 2001
• Gemcitabine and carboplatin for patients with advanced non-small cell lung cancer
  Seminars in Oncology, 2001
• A new mathematical model for relative quantification in real-time RT-PCR
  Nucleic Acids Research, 2001
• Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells
  Oncogene, 2000
• The PI3K‒PDK1 connection: more than just a road to PKB
  Biochemical Journal, 2000